Steven Perrin
Fortune : 3 810 $ au 31/05/2026
Fortune : 3 810 $ au 31/05/2026
Steven N.
Perrin is the founder of Anelixis Therapeutics, Inc., founded in 2013, where the titles held included President, CEO, Treasurer & Director.
Current jobs include Executive Chairman at ALS Therapy Development Foundation, Inc. since 2018 (job started in 2007) and President, Chief Scientific Officer & Director at Eledon Pharmaceuticals, Inc. since 2020.
Former jobs include Associate Director-Molecular Profiling at Biogen, Inc. from 2001 to 2006, Scientist at Biogen MA, Inc., ARIAD Pharmaceuticals, Inc., and Aventis Pharmaceuticals, Inc., Assistant Professor at Boston University, Principal at Hoechst Ariad Genomics Center Llc, and Associate Professor at Boston University School of Medicine.
Education includes an undergraduate degree from Boston College in 1987 and a doctorate from Boston University School of Medicine in 1994.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 1 000 ( 0% ) | 3 810 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | President | 14/09/2020 |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Président | 01/06/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/12/2006 |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anelixis Therapeutics, Inc.
Anelixis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune modulatory drugs for neurodegenerative diseases | Fondateur | - |
Hoechst Ariad Genomics Center Llc
Hoechst Ariad Genomics Center Llc Miscellaneous Commercial ServicesCommercial Services Research center for genomics | Corporate Officer/Principal | - |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoechst Ariad Genomics Center Llc
Hoechst Ariad Genomics Center Llc Miscellaneous Commercial ServicesCommercial Services Research center for genomics | Commercial Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ALS Therapy Development Foundation, Inc.
ALS Therapy Development Foundation, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Anelixis Therapeutics, Inc.
Anelixis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune modulatory drugs for neurodegenerative diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national